Excelsior Biopharma (ROCO:6496) Construction In Progress: NT$2.8 Mil (As of Dec. 2025)


ROCO:6496 Excelsior Biopharma Inc ROCO:6496
51 GF Score
Price NT$24.60
GF Value NT$35.88
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Excelsior Biopharma Construction In Progress?

Excelsior Biopharma ROCO:6496 -0.20% 51 Construction In Progress is NT$2.8 Mil as of Dec. 2025. GuruFocus rates ROCO:6496 with a GF Score™ of 51/100 and a GF Value™ of NT$35.88 (Possible Value Trap). The stock has 3 warning signs investors should review.

Excelsior Biopharma's quarterly construction in progress increased from Jun. 2025 (NT$17.8 Mil) to Sep. 2025 (NT$19.7 Mil) but then declined from Sep. 2025 (NT$19.7 Mil) to Dec. 2025 (NT$2.8 Mil).

Excelsior Biopharma's annual construction in progress declined from Dec. 2023 (NT$27.3 Mil) to Dec. 2024 (NT$5.8 Mil) and declined from Dec. 2024 (NT$5.8 Mil) to Dec. 2025 (NT$2.8 Mil).

Excelsior Biopharma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Excelsior Biopharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Biopharma Construction In Progress Chart

Excelsior Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.29 27.28 5.76 2.81

Excelsior Biopharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.76 14.15 17.77 19.66 2.81
ROCO:6496
51GF Score
Excelsior Biopharma Inc ROCO:6496
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excelsior Biopharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of NT$2.8 Mil mean?
Excelsior Biopharma (ROCO:6496) has a Construction In Progress of NT$2.8 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Excelsior Biopharma and its competitors.
Is Excelsior Biopharma's Construction In Progress too high?
Excelsior Biopharma's current Construction In Progress is NT$2.8 Mil. Overall, Excelsior Biopharma has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Excelsior Biopharma's Construction In Progress compare to ZTS and UTHR?
Excelsior Biopharma's Construction In Progress of NT$2.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Excelsior Biopharma and its competitors. Excelsior Biopharma's current Construction In Progress is NT$2.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Biopharma (ROCO:6496) is currently considered Possible Value Trap. The stock's GF Value™ is NT$35.88, compared to a current price of NT$24.60 — trading 31.4% below its estimated fair value. The current Construction In Progress is NT$2.8 Mil. Excelsior Biopharma's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Excelsior Biopharma (ROCO:6496), the current Construction In Progress is NT$2.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Excelsior Biopharma (ROCO:6496) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Biopharma stock appears to be undervalued. The current stock price of NT$24.60 is trading 31.4% below its estimated GF Value™ of NT$35.88. GuruFocus considers Excelsior Biopharma to be Possible Value Trap.

Key valuation signals for ROCO:6496:

  • Construction In Progress: NT$2.8 Mil
  • GF Value™: NT$35.88 vs. price of NT$24.60 (31.4% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6496 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Excelsior Biopharma Business Description

Address Zhongxiao E. Road, 5Floor, No.508, Sector 7, Nangang District, Taipei, TWN, 11561
Excelsior Biopharma Inc is mainly engaged in western medicines, importing and exporting of Active Pharmaceutical Ingredients, food, cosmecteuticals and development of cosmetics, research, importing, and exporting of technologies, pharmaceutical technologies transfer and cooperative development and improvement. Geographically, it derives revenue from Taiwan, China and others, with majority of revenue earned from Taiwan.
51GF Score

Get the complete analysis for ROCO:6496

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.60
Price
NT$35.88
GF Value